{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Emerging Biotech Leader","title":"Making A Mark In Medical Affairs - Rachel Couchenour : 13","html":"","width":"100%","height":180,"duration":2369,"description":"“I've found that it's usually not the ‘what’ or the ‘how’ that will get me where I need to go with a Senior leader. It's the why. They want to understand the why behind it.” Rachel Couchenour, VP, Global Medical Affairs, Travere Therapeutics. Working cross-functionally. Some would call it a skill. Others would say it’s a talent. For our guest on Episode 13 of the Emerging Biotech Leader, it’s her natural way of being. During her 20+ year career, Rachel Couchenour has held the titles of Assistant Professor, Medical Therapeutic Liaison, Sr Director of Medical Affairs, and now, Vice President of Global Medical Affairs at Travere Therapeutics.   Using Rachel’s experience as a focal point, this episode explores the value of working cross-functionally in emerging biotechs, especially concerning a career in Medical Affairs. Kim and Ramin ask all the right questions, especially uncovering how an investment in Medical Affairs should never be brushed off or perceived as a “nice to have.” Our guest and hosts help emerging Biotech leaders truly understand the impact and significance of Medical Affairs on patients and practitioners. Conversely, they also help Medical Affairs reinforce their value across stakeholders, internal validation, and launches.These are just a few key points touched on during Episode 13. Read below for more! And as always, we thank you for tuning in and being here. A Day In The Life of Medical Affairs To say the Medical Affairs organization has many moving parts is putting it mildly. On any given day, Rachel and her team are responsible for all of the activities and strategies within the Medical Affairs organization at Travere. Functions within her purview include education, scientific communications, evidence generation, medical information, and all the other capabilities that the Medical Affairs organization needs.On the importance of these areas, Kim reminds us of the end result; that we’re all patients, and as patients, we benefit greatly from the...","thumbnail_url":"https://img.transistorcdn.com/ifry0mqC60CO4NUZn9GSCTvcoZ9yKEWu4twnqKmJQQ0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS80NzEy/MTZiMmZlODIyZDI4/OTliMGJiOWQ0ZDUx/MDhmNi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}